145 related articles for article (PubMed ID: 34801883)
1. Utility of a Patient-Reported Symptom and Functioning Assessment Tool for Geriatric Oncology Care in China.
Xue D; Li P; Chen TH; Shi Q; Wang XS
Value Health Reg Issues; 2022 May; 29():28-35. PubMed ID: 34801883
[TBL] [Abstract][Full Text] [Related]
2. Validation and Application of the MD Anderson Symptom Inventory for Traditional Chinese Medicine (MDASI-TCM).
Li Z; Shi Q; Liu M; Jia L; He B; Yang Y; Liu J; Lin H; Lin HK; Li P; Wang XS
J Natl Cancer Inst Monogr; 2017 Nov; 2017(52):. PubMed ID: 29140491
[TBL] [Abstract][Full Text] [Related]
3. Using a symptom-specific instrument to measure patient-reported daily functioning in patients with cancer.
Shi Q; Mendoza TR; Wang XS; Cleeland CS
Eur J Cancer; 2016 Nov; 67():83-90. PubMed ID: 27620946
[TBL] [Abstract][Full Text] [Related]
4. Validation of the Amharic Version of the M. D. Anderson Symptom Inventory and Assessment of Symptoms in Ethiopian Cancer Patients.
Anshabo AT; Migbaru S; Mulu A; Negusu D; Asfaw AA; Awoke D; Tigeneh W; Engidawork E
J Pain Symptom Manage; 2016 May; 51(5):947-53. PubMed ID: 26988847
[TBL] [Abstract][Full Text] [Related]
5. Chinese version of the M. D. Anderson Symptom Inventory: validation and application of symptom measurement in cancer patients.
Wang XS; Wang Y; Guo H; Mendoza TR; Hao XS; Cleeland CS
Cancer; 2004 Oct; 101(8):1890-901. PubMed ID: 15386315
[TBL] [Abstract][Full Text] [Related]
6. The validity and utility of the M. D. Anderson Symptom Inventory in patients with breast cancer: evidence from the symptom outcomes and practice patterns data from the eastern cooperative oncology group.
Mendoza TR; Zhao F; Cleeland CS; Wagner LI; Patrick-Miller LJ; Fisch MJ
Clin Breast Cancer; 2013 Oct; 13(5):325-34. PubMed ID: 23816985
[TBL] [Abstract][Full Text] [Related]
7. Cancer-related symptom assessment in France: validation of the French M. D. Anderson Symptom Inventory.
Guirimand F; Buyck JF; Lauwers-Allot E; Revnik J; Kerguen T; Aegerter P; Brasseur L; Cleeland CS
J Pain Symptom Manage; 2010 Apr; 39(4):721-33. PubMed ID: 20413059
[TBL] [Abstract][Full Text] [Related]
8. Validation and application of a module of the MD Anderson Symptom Inventory for measuring perioperative symptom burden in patients with gynecologic cancer (the MDASI-PeriOp-GYN).
Wang XS; Shi Q; Williams LA; Cleeland CS; Garcia-Gonzalez A; Chen TY; Shahid DR; Ramirez PT; Iniesta MD; Siverand AM; Meyer LA
Gynecol Oncol; 2019 Mar; 152(3):492-500. PubMed ID: 30876494
[TBL] [Abstract][Full Text] [Related]
9. Validation and application of the Arabic version of the M. D. Anderson symptom inventory in Moroccan patients with cancer.
Nejmi M; Wang XS; Mendoza TR; Gning I; Cleeland CS
J Pain Symptom Manage; 2010 Jul; 40(1):75-86. PubMed ID: 20619213
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the psychometric properties and minimally important difference of the MD Anderson Symptom Inventory for malignant pleural mesothelioma (MDASI-MPM).
Mendoza TR; Williams LA; Keating KN; Siegel J; Elbi C; Nowak AK; Hassan R; Cuffel B; Cleeland CS
J Patient Rep Outcomes; 2019 Jun; 3(1):34. PubMed ID: 31209661
[TBL] [Abstract][Full Text] [Related]
11. The validity and utility of the MD Anderson Symptom Inventory in patients with prostate cancer: evidence from the Symptom Outcomes and Practice Patterns (SOAPP) data from the Eastern Cooperative Oncology Group.
Jones D; Zhao F; Fisch MJ; Wagner LI; Patrick-Miller LJ; Cleeland CS; Mendoza TR
Clin Genitourin Cancer; 2014 Feb; 12(1):41-9. PubMed ID: 24126238
[TBL] [Abstract][Full Text] [Related]
12. Patient-Reported Symptom and Functioning Status during the First 12 Months after Chimeric Antigen Receptor T Cell Therapy for Hematologic Malignancies.
Wang XS; Srour SA; Whisenant M; Subbiah IM; Chen TH; Ponce D; Gonzalez AG; Kamal M; Mendoza T; Cleland CS; Kebriaei P; Neelapu SS; Rezvani K; Ahmed S; Shpall E
Transplant Cell Ther; 2021 Nov; 27(11):930.e1-930.e10. PubMed ID: 34265479
[TBL] [Abstract][Full Text] [Related]
13. Symptom burden of cancer patients: validation of the German M. D. Anderson Symptom Inventory: a cross-sectional multicenter study.
Schmidt H; Cleeland CS; Bauer A; Landenberger M; Jahn P
J Pain Symptom Manage; 2015 Jan; 49(1):117-25. PubMed ID: 24858739
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of a patient-reported outcome measure to assess symptom burden after chimeric antigen receptor T-cell therapy.
Wang XS; Srour SA; Mendoza T; Whisenant M; Subbiah I; Gonzalez E; Kamal M; Shen SE; Cleeland C; Kebriaei P; Rezvani K; Neelapu S; Ahmed S; Shpall E
Br J Haematol; 2023 May; 201(4):738-746. PubMed ID: 36733986
[TBL] [Abstract][Full Text] [Related]
15. Measuring symptom burden in patients with cancer during a pandemic: the MD Anderson symptom inventory for COVID-19 (MDASI-COVID).
Williams LA; Whisenant MS; Mendoza TR; Peek AE; Malveaux D; Griffin DK; Ponce DA; Granwehr BP; Sheshadri A; Hutcheson KA; Ali SM; Peterson SK; Heymach JV; Cleeland CS; Subbiah IM
J Patient Rep Outcomes; 2023 May; 7(1):48. PubMed ID: 37237077
[TBL] [Abstract][Full Text] [Related]
16. Assessment of physical function by subjective and objective methods in patients undergoing open gynecologic surgery.
Wang XS; Kamal M; Chen TH; Shi Q; Garcia-Gonzalez A; Iniesta MD; Cleeland CS; Gottumukkala V; Meyer LA
Gynecol Oncol; 2021 Apr; 161(1):83-88. PubMed ID: 33536127
[TBL] [Abstract][Full Text] [Related]
17. Translation and validation of the Chinese version of the MD Anderson symptom inventory for measuring perioperative symptom burden in patients with gynecologic cancer.
Zhang T; Zheng YY; Yang ZR; Shi Q; Wang XS; Zhao J; Yang M; Wu CL; Wang GR
BMC Womens Health; 2021 Jul; 21(1):276. PubMed ID: 34325677
[TBL] [Abstract][Full Text] [Related]
18. Validation and application of a module of the M. D. Anderson Symptom Inventory for measuring multiple symptoms in patients with gastrointestinal cancer (the MDASI-GI).
Wang XS; Williams LA; Eng C; Mendoza TR; Shah NA; Kirkendoll KJ; Shah PK; Trask PC; Palos GR; Cleeland CS
Cancer; 2010 Apr; 116(8):2053-63. PubMed ID: 20166216
[TBL] [Abstract][Full Text] [Related]
19. Modification of existing patient-reported outcome measures: qualitative development of the MD Anderson Symptom Inventory for malignant pleural mesothelioma (MDASI-MPM).
Williams LA; Whisenant MS; Mendoza TR; Haq S; Keating KN; Cuffel B; Cleeland CS
Qual Life Res; 2018 Dec; 27(12):3229-3241. PubMed ID: 30187393
[TBL] [Abstract][Full Text] [Related]
20. Utility of a patient-reported outcome in measuring functional impairment during autologous stem cell transplant in patients with multiple myeloma.
Shah N; Shi Q; Giralt S; Williams L; Bashir Q; Qazilbash M; Champlin RE; Cleeland CS; Wang XS
Qual Life Res; 2018 Apr; 27(4):979-985. PubMed ID: 29260444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
